A
Arcutis Biotherapeutics, Inc.
ARQT US
ARQT USArcutis Biotherapeutics, Inc.
USFIGI: BBG00QN8K4M4
USArcutis Biotherapeutics Says Eczema Treatment Met Primary Endpoints
Arcutis Stock Rises on First TV Ad for Zoryve
Arcutis Biotherapeutics Finance Chief Scott Burrows to Exit
Arcutis Biotherapeutics: Chief Financial Officer Scott Burrows Is Leaving the Co to Pursue an External Opportunity >ARQT
Arcutis Biotherapeutics 2Q Loss/Shr $1.16 >ARQT
Arcutis Biotherapeutics Shares Rise 15% After CVS Caremark Covers Zoryve
Arcutis Biotherapeutics: Chief Comml Officer Ken Lock Stepping Down
Arcutis Biotherapeutics 1Q Loss/Shr $1.31 >ARQT
Arcutis Says Zoryve Has Received Regulatory Approval in Canada
Arcutis: FDA to Review Roflumilast Foam for Seborrheic Dermatitis
For Nvidia Shares, It’s Game On! Again
MDU Resources and AppHarvest See Activist Action
Mercury Systems and GMS See Activist Investor Action
Community West Bancshares, Funko See Activist Investor Action
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.